Description
(AWP Alliance News) - Medacta Group SA reported H1 2026 revenue rose 7% to EUR 368.2 million, while profit for the period fell 30.17% to EUR 41.9 million. IFRS EBITDA dropped 12.4% to EUR 96.8 million, while adjusted EBITDA slipped 1.42% to EUR 97.4 million with an adjusted EBITDA margin of 26.5%, down 2.2 percentage points.
CEO Francesco Siccardi cited an unexpected softening in the US market, though he said adoption from new surgeons remained strong and cost discipline supported margins. The group added 108 employees to 2,273, started operating a fully automated warehouse in Cermenate, Italy, and acquired land in Tennessee for a new US headquarters and manufacturing capacity with investment of up to USD 85 million over five years.
Medacta reaffirmed its 2026 target for revenue growth of 10% to 14% and around 50 bps expansion in adjusted EBITDA margin, both in constant currency.
https://www.publicnow.com/view/B3C68C3740DCCB06D035E12B9D5C7D152B055D0E…
Disclaimer: This news brief was created using generative artificial intelligence. Medacta Group SA published the original content used to generate this news brief via EQS News on September 09, 2026, and is solely responsible for the information contained therein.
